loadpatents
name:-0.032748937606812
name:-0.019557952880859
name:-0.007072925567627
Pessi; Antonello Patent Filings

Pessi; Antonello

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pessi; Antonello.The latest application filed is for "long-acting co-agonists of the glucagon and glp-1 receptors".

Company Profile
6.19.30
  • Pessi; Antonello - D'Europa IT
  • Pessi; Antonello - Rome IT
  • Pessi; Antonello - Roma IT
  • Pessi; Antonello - Pommezia IT
  • Pessi; Antonello - Pomezia N/A IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors
App 20200392196 - Palani; Anandan ;   et al.
2020-12-17
Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells
Grant 10,836,792 - Carriero , et al. November 17, 2
2020-11-17
Long-acting co-agonists of the glucagon and GLP-1 receptors
Grant 10,793,615 - Palani , et al. October 6, 2
2020-10-06
Co-agonists of the glucagon and GLP-1 receptors
Grant 10,493,125 - Palani , et al. De
2019-12-03
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors
App 20190338008 - Palani; Anandan ;   et al.
2019-11-07
Co-agonists of the glucagon and GLP-1 receptors
Grant 10,413,593 - Bianchi , et al. Sept
2019-09-17
Retro-inverso Peptide Inhibitors Of Cell Migration, Extracellular Matrix And Endothelial Invasion By Tumor Cells
App 20190135863 - Carriero; Maria Vincenza ;   et al.
2019-05-09
Co-agonists Of The Glucagon And Glp-1 Receptors
App 20180339017 - Palani; Anandan ;   et al.
2018-11-29
Co-agonists Of The Glucagon And Glp-1 Receptors
App 20170360893 - Bianchi; Elisabetta ;   et al.
2017-12-21
Oxyntomodulin analogs
Grant 9,593,155 - Carrington , et al. March 14, 2
2017-03-14
Co-agonists Of The Glucagon And Glp-1 Receptors
App 20160114000 - Bianchi; Elisabetta ;   et al.
2016-04-28
Oxyntomodulin Analogs
App 20150307580 - CARRINGTON; Paul E. ;   et al.
2015-10-29
Glucagon/GLP-1 receptor co-agonists
Grant 8,969,294 - Bianchi , et al. March 3, 2
2015-03-03
Non-self T-cell Epitope Fused To An Antibody That Recognises A Tumour-specific Cell-surface Receptor And Uses Thereof
App 20140161826 - Pessi; Antonello
2014-06-12
Cholesterol Derivatives Of Inhibitors Of Viral Fusion
App 20140094405 - PESSI; Antonello ;   et al.
2014-04-03
Cholesterol derivatives of inhibitors of viral fusion
Grant 8,629,101 - Pessi , et al. January 14, 2
2014-01-14
Multimeric Inhibitors of Viral Fusion and Uses Thereof
App 20130196903 - Pessi; Antonello
2013-08-01
Lipid-conjugated Antibodies
App 20130150563 - Pessi; Antonello ;   et al.
2013-06-13
Glucagon/glp-1 Receptor Co-agonists
App 20130090286 - Bianchi; Elisabetta ;   et al.
2013-04-11
Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
Grant 8,268,779 - Sinha Roy , et al. September 18, 2
2012-09-18
Oxyntomodulin Analogs
App 20120165503 - Carrington; Paul E. ;   et al.
2012-06-28
Neuromedin U Receptor Agonists And Uses Thereof
App 20110301079 - Marsh; Donald J. ;   et al.
2011-12-08
Pharmaceutical Composition Comprising Oxyntomodulin Derivatives And A Method For Reducing Body Weight Using The Composition
App 20110183902 - Sinha Roy; Ranabir ;   et al.
2011-07-28
Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
Grant 7,928,058 - Sinha Roy , et al. April 19, 2
2011-04-19
Apoa-1 Peptide Mimetics
App 20110046056 - Bianchi; Elisabetta ;   et al.
2011-02-24
Cholesterol Derivatives Of Inhibitors Of Viral Fusion
App 20100305028 - Pessi; Antonello ;   et al.
2010-12-02
Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity
Grant 7,811,577 - Bianchi , et al. October 12, 2
2010-10-12
Oxyntomodulin Derivatives
App 20100144617 - Sinha Roy; Ranabir ;   et al.
2010-06-10
Method for Shielding Functional Sites or Epitopes on Proteins
App 20100092505 - Bianchi; Elisabetta ;   et al.
2010-04-15
Neuromedin U Receptor Agonists And Uses Thereof
App 20100075907 - Marsh; Donald J. ;   et al.
2010-03-25
Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity
App 20090104220 - Bianchi; Elisabetta ;   et al.
2009-04-23
Stable Peptide Mimetic of Hiv Gp41 Fusion Intermediate
App 20070224212 - Bianchi; Elisabetta ;   et al.
2007-09-27
HCV NS3 protease inhibitors
Grant 6,995,177 - Bianchi , et al. February 7, 2
2006-02-07
Influenza virus vaccine
App 20040223976 - Bianchi, Elisabetta ;   et al.
2004-11-11
Conjugates of aminodrugs
App 20040038871 - Fattori, Daniela ;   et al.
2004-02-26
Vectors for dna delivery
App 20030207400 - Bianchi, Elisabetta ;   et al.
2003-11-06
Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease
Grant 6,197,536 - Steinkuhler , et al. March 6, 2
2001-03-06
Immunoenzymatic single-plate ELISA method with competitive inhibition for detecting antisporozoite antibodies of plasmodium falciparum
Grant 5,374,530 - Nuzzolo , et al. December 20, 1
1994-12-20
Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines
Grant 5,196,512 - Bianchi , et al. March 23, 1
1993-03-23
Retro-inverso hexapeptide neurotensin analogs, process for their preparation and pharmaceutical compositions containing them
Grant 4,732,890 - Bonelli , et al. March 22, 1
1988-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed